Medpace Holdings, Inc. (MEDP)

Medpace Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,157	2,109	1,886	1,460	1,142	925.93
Revenue Growth (YoY)	9.87%	11.84%	29.17%	27.80%	23.38%	7.54%
Cost of Revenue	688.42	682.1	638.25	534.89	441.09	354.43
Gross Profit	1,468	1,427	1,248	925.11	701.29	571.5
Selling, General & Admin	194	180.18	161.35	131.4	108.42	92.16
Other Operating Expenses	788.65	770.65	723.09	492.67	373.13	292.77
Operating Expenses	1,012	980.09	910.77	646.41	502.67	404.46
Operating Income	456.32	446.87	336.83	278.7	198.62	167.04
Interest Expense	-	-	-0.49	-2.91	-0.11	-
Interest & Investment Income	27.34	25	-	-	-	0.31
Currency Exchange Gain (Loss)	-0.5	-0.5	-1.93	3.86	2.78	0.51
Other Non Operating Income (Expenses)	-1.86	4.55	1.27	3.21	0.56	0.67
EBT Excluding Unusual Items	481.31	475.92	335.68	282.86	201.85	168.53
Pretax Income	481.31	475.92	335.68	282.86	201.85	168.53
Income Tax Expense	64.92	71.54	52.87	37.49	20	23.15
Net Income	416.39	404.39	282.81	245.37	181.85	145.38
Preferred Dividends & Other Adjustments	-0	0.04	0.19	0.16	0.46	0.46
Net Income to Common	416.39	404.34	282.62	245.21	181.39	144.93
Net Income Growth	33.24%	42.99%	15.26%	34.93%	25.08%	44.74%
Shares Outstanding (Basic)	31	31	31	32	36	36
Shares Outstanding (Diluted)	32	32	32	34	38	38
Shares Change (YoY)	0.03%	0.54%	-5.44%	-10.68%	-0.03%	0.35%
EPS (Basic)	13.50	13.06	9.20	7.57	5.06	4.07
EPS (Diluted)	13.09	12.63	8.88	7.28	4.81	3.84
EPS Growth	33.36%	42.23%	21.98%	51.35%	25.26%	43.82%
Free Cash Flow	540.93	572.27	396.73	351.17	235.06	227.34
Free Cash Flow Per Share	17.00	17.88	12.46	10.43	6.24	6.03
Gross Margin	68.08%	67.66%	66.16%	63.36%	61.39%	61.72%
Operating Margin	21.16%	21.19%	17.86%	19.09%	17.39%	18.04%
Profit Margin	19.31%	19.17%	14.99%	16.79%	15.88%	15.65%
Free Cash Flow Margin	25.08%	27.13%	21.04%	24.05%	20.58%	24.55%
EBITDA	485.51	476.12	363.15	301.04	219.73	186.57
EBITDA Margin	22.51%	22.57%	19.26%	20.62%	19.23%	20.15%
D&A For EBITDA	29.19	29.25	26.33	22.34	21.12	19.53
EBIT	456.32	446.87	336.83	278.7	198.62	167.04
EBIT Margin	21.16%	21.19%	17.86%	19.09%	17.39%	18.04%
Effective Tax Rate	13.49%	15.03%	15.75%	13.26%	9.91%	13.73%
Advertising Expenses	-	1.5	1.5	1.3	1.2	0.7

Updated Apr 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q